Discovery of 4-benzoylamino-N-(prop-2-yn-1-yl)benzamides as novel microRNA-21 inhibitors
- 1 October 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (19) , 6510-6519
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81401289)
This publication has 16 references indexed in Scilit:
- The Oncogenic MicroRNA-21 Inhibits the Tumor Suppressive Activity of FBXO11 to Promote TumorigenesisJournal of Biological Chemistry, 2015
- Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTENBiochemical and Biophysical Research Communications, 2014
- Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growthBiomedicine & Pharmacotherapy, 2013
- High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancerEuropean Journal of Cancer, 2013
- miR-21 inhibitor sensitizes human OSCC cells to cisplatinMolecular Biology Reports, 2012
- Apoptosis and the target genes of microRNA-21Chinese Journal of Cancer, 2011
- Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivotumor growthBreast Cancer Research, 2011
- MicroRNA-21: A novel therapeutic target in human cancerCancer Biology & Therapy, 2010
- MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxolBMC Cancer, 2010
- A microRNA expression signature of human solid tumors defines cancer gene targetsProceedings of the National Academy of Sciences, 2006